Waggoner S E, Wang X
Department of Obstetrics and Gynecology, University of Chicago Medical Center, Illinois 60637.
Gynecol Oncol. 1994 Oct;55(1):91-5. doi: 10.1006/gyno.1994.1254.
Nicotine is concentrated in the cervical mucus of smokers relative to serum levels. In this experiment, the effect of nicotine on cellular proliferation of human ectocervical, endocervical, malignant, and human papillomavirus (HPV) 16 DNA-transformed cervical cell lines was studied. Ectocervical and endocervical cell lines were derived from benign hysterectomy specimens and cultured in keratinocyte growth medium. HPV 16 DNA-transformed cell lines were derived through transfection of ectocervical cells with cloned HPV 16 DNA. HPV-transformed lines and malignant cell lines established from three women with newly diagnosed cervical cancer were maintained in E-media with 5% fetal calf serum. Cells (2500-5000) were cultured in 96-well tissue culture plates with varying concentrations of nicotine (100 to 10 mg/ml) and proliferation was assessed 72 hr later with a semiautomated colorimetric assay. Experiments were performed three times and proliferation of nicotine-exposed cells was compared to unexposed cells with one-way analysis of variance. Nicotine, at 100 ng/ml to 10 micrograms/ml, significantly stimulated epithelial cell growth in two ectocervical and three HPV DNA-transformed cell lines (proliferation 118-180% of control, P < .05). Nicotine at 100 ng/ml to 10 micrograms/ml did not significantly alter proliferation of four endocervical, three malignant, and two other ectocervical cell lines. Toxic effects of nicotine (> 50% inhibition of cellular proliferation) were noted between 100 micrograms/ml and 10 mg/ml and exceed the concentrations of nicotine reported in smoker's cervical mucus. These findings demonstrate that nicotine, in physiologically attainable concentrations, does not impair and occasionally enhances the proliferation of human cervical cells in vitro. The selective mitogenic effect noted among normal ectocervical and HPV-transformed ectocervical cells may relate to epidemiologic studies showing, among smokers, an increased risk of squamous cell carcinoma, and not adenocarcinoma, of the cervix.
相对于血清水平,尼古丁在吸烟者的宫颈黏液中浓度更高。在本实验中,研究了尼古丁对人宫颈外、宫颈内、恶性以及人乳头瘤病毒(HPV)16 DNA转化的宫颈细胞系细胞增殖的影响。宫颈外和宫颈内细胞系源自良性子宫切除标本,并在角质形成细胞生长培养基中培养。HPV 16 DNA转化细胞系通过用克隆的HPV 16 DNA转染宫颈外细胞获得。从三名新诊断为宫颈癌的女性建立的HPV转化细胞系和恶性细胞系在含5%胎牛血清的E培养基中培养。将细胞(2500 - 5000个)接种于96孔组织培养板中,加入不同浓度的尼古丁(100至10 mg/ml),72小时后用半自动比色法评估细胞增殖情况。实验重复进行三次,用单因素方差分析比较尼古丁处理组细胞与未处理组细胞的增殖情况。尼古丁浓度在100 ng/ml至10 μg/ml时,显著刺激了两个宫颈外细胞系和三个HPV DNA转化细胞系的上皮细胞生长(增殖为对照组的118 - 180%,P < .05)。尼古丁浓度在100 ng/ml至10 μg/ml时,未显著改变四个宫颈内细胞系、三个恶性细胞系以及另外两个宫颈外细胞系的增殖情况。在100 μg/ml至10 mg/ml之间观察到尼古丁的毒性作用(细胞增殖抑制> 50%),该浓度超过了吸烟者宫颈黏液中报道的尼古丁浓度。这些发现表明,在生理可达到的浓度下,尼古丁不会损害体外培养的人宫颈细胞的增殖,偶尔还会增强其增殖。在正常宫颈外细胞和HPV转化的宫颈外细胞中观察到的选择性促有丝分裂作用,可能与流行病学研究结果相关,即吸烟者患宫颈鳞状细胞癌而非腺癌的风险增加。